Biology Reference
In-Depth Information
Ketema, T., Getahun, K., Bacha, K., 2011. Therapeutic efficacy of chloroquine for treat-
ment of
Plasmodium vivax
malaria cases in Halaba district, South Ethiopia. Parasit.
Vectors 4, 46.
Khantikul, N., Butraporn, P., Kim, H.S., Leemingsawat, S., Tempongko, M.A., et al., 2009.
Adherence to antimalarial drug therapy among vivax malaria patients in northern Thai-
land. J. Health Popul. Nutr. 27, 4-13.
Kim, S., Nguon, C., Guillard, B., Duong, S., Chy, S., et al., 2011a. Performance of the Care-
Start
TM
G6PD deficiency screening test, a point-of-care diagnostic for primaquine ther-
aphy screening. PLoS ONE 6, 12.
Kim,Y.K., Kim, C., Park, I., Kim, H.Y., Choi, J.Y., et al., 2011b. Therapeutic efficacy of chlo-
roquine in
Plasmodium vivax
and the pvmdr1 polymorphisms in the Republic of Korea
under mass chemoprophylaxis. Am. J. Trop. Med. Hyg. 84, 532-534.
Kimura, M., Miyake, H., Kim, H.S., Tanabe, M., Arai, M., et al., 1995. Species-specific PCR
detection of malaria parasites by microtiter plate hybridization: clinical study with
malaria patients. J. Clin. Microbiol. 33, 2342-2346.
Kochar, D.K., Saxena, V., Singh, N., Kochar, S.K., Kumar, S.V., et al., 2005.
Plasmodium vivax
malaria. Emerg. Infect. Dis. 11, 132-134.
Koepfli, C., Mueller, I., Marfurt, J., Goroti, M., Sie, A., et al., 2009. Evaluation of
Plasmodium
vivax
genotyping markers for molecular monitoring in clinical trials. J. Infect. Dis.
199, 1074-1080.
Kolaczinski, K., Durrani, N., Rahim, S., Rowland, M., 2007. Sulfadoxine-pyrimethamine
plus artesunate compared with chloroquine for the treatment of vivax malaria in areas
co-endemic for
Plasmodium falciparum
and
P. vivax
: a randomised non-inferiority trial in
eastern Afghanistan. Trans. R. Soc. Trop. Med. Hyg. 101, 1081-1087.
Kotwal, R.S., Wenzel, R.B., Sterling, R.A., Porter, W.D., Jordan, N.N., et al., 2005. An out-
break of malaria in US Army Rangers returning from Afghanistan. J. Am. Med. Assoc.
293, 212-216.
Krotoski, W.A., Garnham, P.C., Cogswell, F.B., Collins, W.E., Bray, R.S., et al.,
1986. Observations on early and late post-sporozoite tissue stages in primate
malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North
Korean strains of
Plasmodium vivax
in the chimpanzee. Am. J. Trop. Med. Hyg.
35, 263-274.
Krudsood, S., Wilairatana, P., Tangpukdee, N., Chalermrut, K., Srivilairit, S., et al., 2006.
Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of
Plasmo-
dium vivax
malaria in Thailand. Korean J. Parasitol. 44, 221-228.
Krudsood, S., Tangpukdee, N., Muangnoicharoen, S., Thanachartwet,V., Luplertlop, N., et al.,
2007. Clinical efficacy of chloroquine versus artemether-lumefantrine for
Plasmodium
vivax
treatment in Thailand. Korean J. Parasitol. 45, 111-114.
Krudsood, S., Tangpukdee, N., Wilairatana, P., Phophak, N., Baird, J.K., et al., 2008. High-
dose primaquine regimens against relapse of
Plasmodium vivax
malaria. Am. J. Trop. Med.
Hyg. 78, 736-740.
Kumar, S., Melzer, M., Dodds, P., Watson, J., Ord, R., 2007.
P. vivax
malaria complicated by
shock and ARDS. Scand. J. Infect. Dis. 39, 255-256.
Lacy, M.D., Maguire, J.D., Barcus, M.J., Ling, J., Bangs, M.J., et al., 2002. Atovaquone/progua-
nil therapy for
Plasmodium falciparum
and
Plasmodium vivax
malaria in Indonesians who
lack clinical immunity. Clin. Infect. Dis. 35, e92-95.
Lawn, S.D., Krishna, S., Jarvis, J.N., Joet, T., Macallan, D.C., 2003. Case reports: perni-
cious complications of benign tertian malaria. Trans. R. Soc. Trop. Med. Hyg. 97,
551-553.
Lee, S.W., Lee, M., Lee, D.D., Kim, C., Kim,Y.J., et al., 2009. Biological resistance of hydroxy-
chloroquine for
Plasmodium vivax
malaria in the Republic of Korea. Am. J. Trop. Med.
Hyg. 81, 600-604.
